An analysis by Oak Ridge National Laboratory shows that using less-profitable farmland to grow bioenergy crops such as switchgrass could fuel not only clean energy, but also gains in biodiversity.
The U.S. Department of Energy’s Office of Science announced allocations of supercomputer access to 51 high-impact computational science projects for 2022 through its Innovative and Novel Computational Impact on Theory and Experiment, or INCITE, program.
A team including researchers from the Department of Energy’s Oak Ridge National Laboratory has developed a digital tool to better monitor a condition known as Barrett’s esophagus, which affects more than 3 million people in the United States.
A new modeling capability developed at Oak Ridge National Laboratory incorporates important biogeochemical processes happening in river corridors for a clearer understanding of how water quality will be impacted by climate change, land use and
New data hosted through the Atmospheric Radiation Measurement Data Center at Oak Ridge National Laboratory will help improve models that predict climate change effects on the water supply in the Colorado River Basin.
Oak Ridge National Laboratory worked with Colorado State University to simulate how a warming climate may affect U.S. urban hydrological systems.
L&N STEM Academy senior Tyler Duckworth has been named recipient of the 2021 UT-Battelle Scholarship to attend the University of Tennessee.
The Department of Energy’s Oak Ridge National Laboratory has licensed its award-winning artificial intelligence software system, the Multinode Evolutionary Neural Networks for Deep Learning, to General Motors for use in vehicle technology and design.
The U.S. Department of Energy’s Innovative and Novel Computational Impact on Theory and Experiment, or INCITE, program is seeking proposals for high-impact, computationally intensive research campaigns in a broad array of science, engineering and computer science domains.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.